Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOTEGRAVIR\RILPIVIRINE: 5,026 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
5,026
Total FAERS Reports
101 (2.0%)
Deaths Reported
224
Hospitalizations
5,026
As Primary/Secondary Suspect
23
Life-Threatening
16
Disabilities

First Report: 10121111 · Latest Report: 20250919

What Are the Most Common CABOTEGRAVIR\RILPIVIRINE Side Effects?

#1 Most Reported
Product dose omission issue
655 reports (13.0%)
#2 Most Reported
Injection site pain
545 reports (10.8%)
#3 Most Reported
Viral load increased
428 reports (8.5%)

All CABOTEGRAVIR\RILPIVIRINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Product dose omission issue 655 13.0% 0 32
Injection site pain 545 10.8% 1 13
Viral load increased 428 8.5% 0 3
Off label use 366 7.3% 1 2
Pain 256 5.1% 1 11
Virologic failure 255 5.1% 0 2
Product use in unapproved therapeutic environment 239 4.8% 0 0
Pathogen resistance 202 4.0% 0 1
Product storage error 168 3.3% 0 2
Inappropriate schedule of product administration 162 3.2% 1 36
Product complaint 158 3.1% 0 0
Injection site nodule 153 3.0% 0 0
Blood hiv rna increased 125 2.5% 0 1
Fatigue 123 2.5% 2 11
Wrong technique in device usage process 109 2.2% 0 2
Viral mutation identified 106 2.1% 0 1
Condition aggravated 103 2.1% 1 8
Exposure during pregnancy 99 2.0% 0 0
Pyrexia 99 2.0% 1 14
Depression 92 1.8% 0 9

Who Reports CABOTEGRAVIR\RILPIVIRINE Side Effects? Age & Gender Data

Gender: 28.4% female, 71.6% male. Average age: 44.8 years. Most reports from: US. View detailed demographics →

Is CABOTEGRAVIR\RILPIVIRINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 1
2017 1 0 0
2018 2 0 0
2019 3 0 0
2021 110 0 7
2022 389 7 12
2023 519 16 25
2024 605 23 31
2025 286 15 36

View full timeline →

What Is CABOTEGRAVIR\RILPIVIRINE Used For?

IndicationReports
Product used for unknown indication 2,678
Hiv infection 2,044
Illness 52
Hiv test 35
Acquired immunodeficiency syndrome 19
Antiretroviral therapy 18
Hiv carrier 15
Hiv test positive 15
Asymptomatic hiv infection 14
Hiv infection cdc group iii 14

CABOTEGRAVIR\RILPIVIRINE vs Alternatives: Which Is Safer?

CABOTEGRAVIR\RILPIVIRINE vs CABOZANTINIB CABOTEGRAVIR\RILPIVIRINE vs CABOZANTINIB S-MALATE CABOTEGRAVIR\RILPIVIRINE vs CAFFEINE CABOTEGRAVIR\RILPIVIRINE vs CALASPARGASE PEGOL CABOTEGRAVIR\RILPIVIRINE vs CALASPARGASE PEGOL-MKNL CABOTEGRAVIR\RILPIVIRINE vs CALCIFEDIOL CABOTEGRAVIR\RILPIVIRINE vs CALCIPOTRIENE CABOTEGRAVIR\RILPIVIRINE vs CALCITONIN CABOTEGRAVIR\RILPIVIRINE vs CALCITONIN SALMON CABOTEGRAVIR\RILPIVIRINE vs CALCITRIOL

Official FDA Label for CABOTEGRAVIR\RILPIVIRINE

Official prescribing information from the FDA-approved drug label.